Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05424484

Mesh Augmented Reinforcement of Abdominal Wall Suture Line to Limit the Rate of Incisional Hernia Occurrence

Mesh Augmented Reinforcement of Abdominal Wall Suture Line in Patients Undergoing Midline Laparotomy to Limit the Rate of Incisional Hernia Occurrence

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
123 (actual)
Sponsor
Medtronic - MITG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this prospective, pivotal, multi-center, single-arm, pre-market, investigational clinical study is to assess the safety and performance of Deternia™ Self-Gripping Resorbable Mesh when used for suture line reinforcement after midline laparotomy in clean and clean-contaminated fields (CDC Classification I and II). Data from this study will be used to support market applications. The indication under investigation is reinforcement of midline laparotomy to limit the rate of incisional hernia (IH) in clean and clean-contaminated surgeries (CDC Classification I and II).

Detailed description

The primary objective of this investigation is to evaluate the performance of Deternia™ Self-Gripping Resorbable Mesh when used for suture line reinforcement after elective midline laparotomy in clean and clean-contaminated fields (CDC Classification I and II) at 12 months post-operatively and to demonstrate expected performance in terms of rate of IH occurrence relative to a performance goal (based on historical data on primary laparotomy incision suture closure with small bites only). The secondary objectives are to evaluate the safety and performance of Deternia™ Self-Gripping Resorbable Mesh when used for suture line reinforcement after elective midline laparotomy in clean and clean contaminated fields (CDC Classification I and II) within 36 months postoperatively.

Conditions

Interventions

TypeNameDescription
DEVICESelf-Gripping Resorbable MeshSelf-Gripping Resorbable Mesh used for suture line reinforcement after midline laparotomy in clean and clean-contaminated fields (CDC Classification I and II).

Timeline

Start date
2022-11-22
Primary completion
2026-05-01
Completion
2028-09-01
First posted
2022-06-21
Last updated
2025-11-19

Locations

13 sites across 5 countries: Croatia, Germany, Netherlands, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT05424484. Inclusion in this directory is not an endorsement.